1st ProCAncer-I Project Dissemination Event in Vienna

An AI Platform integrating imaging data and models, supporting precision care through prostate cancer’s continuum: In Europe, prostate cancer (PC) is the second most frequent type of cancer in men and the third most lethal. Current clinical practices lead to overdiagnosis and overtreatment, necessitating more effective tools for discriminating between aggressive and non-aggressive disease. The EU-funded ProCAncer-I project proposes to develop advanced artificial intelligence models to address unmet clinical needs: diagnosis, metastases detection and prediction of response to treatment. To achieve this, partners will generate a large interoperable repository of health images, and a scalable high-performance computing platform hosting the largest collection of PC Magnetic Resonance Images used for developing robust PC AI models. To ensure the rapid clinical implementation of the models developed, the project’s partners will robustly monitor performance, accuracy and reproducibility. 

Welcome by Coordinating Team

We are very glad to lead a very ambitious and health-driven project that could end to alleviating and helping thousands of men to tackle prostate cancer in a more personalized way supporting a better quality of life

The Coordinating Team

Manolis Tsiknakis

Prof. Manolis Tsiknakis

Dr. Nikolaos Papanikolaou
(Scientific Manager)

Prof. Kostas Marias
(Technical Manager)

Prof. Daniele Regge
(Clinical Manager)

The ProCAncer-I project is one of the founding projects of the FUTURE-AI.

FUTURE-AI is an international, multi-stakeholder initiative for defining and maintaining concrete guidelines that will facilitate the design, development, validation, and deployment of trustworthy AI solutions in medical imaging based on six guiding principles: Fairness, Universality, Traceability, Usability, Robustness, and Explainability.

Project Information

Months (Duration)

Euros (Total Budget )

Grant Agreement Nr.


This project has received funding from the European Union’s Horizon 2020 research and innovation programme



AI for Health Imaging


European Cancer Imaging Initiative launch event

European Cancer Imaging Initiative launch event

The Commission is organising a hybrid event on 23 January 2023 in Brussels to mark the launch of the Cancer Imaging Initiative, one of the Flagship Initiatives of the Europe’s Beating Cancer Plan. This 2.5-hour event will present the policy background and the Cancer...

"#AI and ML innovations have the potential to revolutionize medical research by giving researchers access to unprecedented amounts of data that could lead to novel treatments or cures for diseases."
#cancer #reasearch #health_data #data_imaging

Meet the team! 👇
Agios Savvas Hospital is the main anti-cancer hospital in Greece, with a large volume of patients. Treats all kinds of tumors, with emphasis on breast, lung, prostate, pancreatic and melanoma and participates in multiple phase II & III clinical trials.

👏 New publication! 👏
"Virtual biopsy in abdominal pathology: where do we stand?" Read more 👇 https://www.birpublications.org/doi/10.1259/bjro.20220055#.ZBlyCK53F1k.twitter
@ProCAncer_I @BJR_Radiology #health #data

An article from our partner, Gloria Ribas, was published in the special Medical Edition of the "El País" newspaper. Read more 👉 https://bit.ly/3yqdKe8
#H2020 #Eufunded #CancerManagement #cancer #reasearch #data_imaging #ai #procancer_i #elpais

Big week for the PI-CAI challenge! Read more 👇

Load More...

Stay in touch!